BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Piceatannol

piceatannol-3'-O-glucopyranoside [Supplementary Concept] activates eNOS via inhibition of arginase; isolated from rhubarb, Rheum undulatum; structure in first source Heading Mapped to: Glucosides Stilbenes

300+ PubMed studies analyzed · 1 RCTs · Evidence Score: 36.5

Research Domains

Piceatannol has been studied across 22 research domains including 🔬 Oncology, ⏳ Longevity & Aging, 🔬 Inflammation, 🧘 Stress & Anxiety, 🫁 Liver & Detox. The primary research focus is 🔬 Oncology with 32% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Piceatannol, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Emodin
26 shared targets
Luteolin
34 shared targets
Methyldopa
21 shared targets
Cisplatin
16 shared targets
myricetin-3-O-galactopyranoside
35 shared targets
Aurintricarboxylic
24 shared targets
ag490
16 shared targets
2-Methoxyestradiol
15 shared targets
Quercetin
41 shared targets
tyrphostin
20 shared targets
Loading evidence profile...

This evidence profile for Piceatannol is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.